Brunel University Research Archive (BURA) >
Special Research Institutes >
Health Economics Research Group (HERG) >

Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/4632

Title: Value based pricing for NHS drugs: An opportunity not to be missed?
Authors: Claxton, K
Briggs, AH
Buxton, MJ
Culyer, AJ
McCabe, C
Walker, S
Sculpher, MJ
Publication Date: 2008
Publisher: British Medical Journal
Citation: BMJ 336(7638): 251-254, Feb 2008
Abstract: The policy debate about price, value, and innovation in pharmaceuticals is at a critical stage for the NHS. Karl Claxton and colleagues describe the key principles of value based pricing and consider some of the concerns about such a scheme
Description: The official puclished version of the article can be found at the link below
URI: http://www.bmj.com/content/336/7638/251
http://bura.brunel.ac.uk/handle/2438/4632
DOI: http://dx.doi.org/10.1136/bmj.39434.500185.25
ISSN: 0959-8138
Appears in Collections:Health Economics Research Group (HERG)

Files in This Item:

File Description SizeFormat
Fulltext.pdf427.65 kBAdobe PDFView/Open

Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.